• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱切除术后导管出血揭示孤立性远端输尿管复发:腹腔镜肾输尿管切除术及监测经验

Conduit Bleeding Unmasks Isolated Distal Ureter Recurrence After Radical Cystectomy: Lessons in Laparoscopic Nephroureterectomy and Surveillance.

作者信息

Yedulla Reddy Roshan, Ravichandran Rajan, Singh Rubina, T Chandru, Kumaresan Natarajan

机构信息

Urology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

出版信息

Cureus. 2025 Jul 26;17(7):e88821. doi: 10.7759/cureus.88821. eCollection 2025 Jul.

DOI:10.7759/cureus.88821
PMID:40861545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12377796/
Abstract

Recurrent upper-tract urothelial carcinoma (UTUC) following radical cystectomy is an uncommon but clinically significant occurrence. We present the case of a 48-year-old man with a history of muscle-invasive bladder cancer (pT2N0M0) treated with radical cystectomy and Bricker ileal conduit diversion. He remained recurrence-free on structured surveillance for 42 months before developing isolated, painless stomal bleeding without associated systemic symptoms. Cross-sectional imaging revealed a 1.6 cm enhancing mass at the left uretero-enteric anastomosis with mild proximal hydroureteronephrosis, and PET-CT confirmed localized hypermetabolic activity without nodal or distant spread. The patient underwent laparoscopic radical nephroureterectomy with en-bloc excision of the distal ureter and limited conduit revision. Histopathology confirmed high-grade invasive UTUC (pT2) with lympho-vascular invasion, negative surgical margins, and a negative hilar node. He subsequently received four cycles of adjuvant gemcitabine-cisplatin (GC) chemotherapy. 18 months postoperatively, the patient remains asymptomatic with preserved renal function and no evidence of radiological recurrence. This case highlights the importance of considering upper-tract recurrence in the differential diagnosis of conduit bleeding. It supports timely cross-sectional imaging and oncologic resection as key steps in achieving long-term disease control.

摘要

根治性膀胱切除术后复发性上尿路尿路上皮癌(UTUC)虽不常见,但具有临床意义。我们报告一例48岁男性病例,该患者有肌肉浸润性膀胱癌(pT2N0M0)病史,接受了根治性膀胱切除术及Bricker回肠导管改道术。在进行了42个月的结构化监测且无复发后,他出现了孤立的、无痛的造口出血,无相关全身症状。横断面成像显示左输尿管肠吻合处有一个1.6 cm的强化肿块,近端轻度输尿管肾盂积水,PET-CT证实为局限性高代谢活性,无淋巴结或远处转移。患者接受了腹腔镜根治性肾输尿管切除术,同时整块切除远端输尿管并对导管进行有限修复。组织病理学证实为高级别浸润性UTUC(pT2),伴有淋巴血管浸润,手术切缘阴性,肾门淋巴结阴性。随后,他接受了四个周期的吉西他滨-顺铂(GC)辅助化疗。术后18个月,患者无症状,肾功能保留,无影像学复发证据。该病例强调了在导管出血的鉴别诊断中考虑上尿路复发的重要性。它支持及时进行横断面成像和肿瘤切除,作为实现长期疾病控制的关键步骤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/03fba05d8ad7/cureus-0017-00000088821-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/d6ef31136e21/cureus-0017-00000088821-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/1b7bb15cf2dc/cureus-0017-00000088821-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/60f63bb8c2f4/cureus-0017-00000088821-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/f28115a64658/cureus-0017-00000088821-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/0ba2d09aa79a/cureus-0017-00000088821-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/03fba05d8ad7/cureus-0017-00000088821-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/d6ef31136e21/cureus-0017-00000088821-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/1b7bb15cf2dc/cureus-0017-00000088821-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/60f63bb8c2f4/cureus-0017-00000088821-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/f28115a64658/cureus-0017-00000088821-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/0ba2d09aa79a/cureus-0017-00000088821-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae9/12377796/03fba05d8ad7/cureus-0017-00000088821-i06.jpg

相似文献

1
Conduit Bleeding Unmasks Isolated Distal Ureter Recurrence After Radical Cystectomy: Lessons in Laparoscopic Nephroureterectomy and Surveillance.根治性膀胱切除术后导管出血揭示孤立性远端输尿管复发:腹腔镜肾输尿管切除术及监测经验
Cureus. 2025 Jul 26;17(7):e88821. doi: 10.7759/cureus.88821. eCollection 2025 Jul.
2
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.根治性膀胱切除术后残余尿路上皮转归的系统评价
Eur Urol. 2017 Apr;71(4):545-557. doi: 10.1016/j.eururo.2016.09.035. Epub 2016 Oct 6.
3
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.使用肠段进行尿流改道和膀胱重建/替代,用于治疗顽固性尿失禁或膀胱切除术后。
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD003306. doi: 10.1002/14651858.CD003306.pub2.
4
Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.机器人辅助根治性膀胱切除术的肿瘤学和功能结局的系统评价和累积分析。
Eur Urol. 2015 Mar;67(3):402-22. doi: 10.1016/j.eururo.2014.12.008. Epub 2015 Jan 2.
5
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.保留肾单位手术与根治性肾输尿管切除术治疗上尿路上皮癌的肿瘤学结局:EAU 非肌肉浸润性膀胱癌指南小组的系统评价。
Eur Urol. 2016 Dec;70(6):1052-1068. doi: 10.1016/j.eururo.2016.07.014. Epub 2016 Jul 28.
6
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.对于顽固性尿失禁或膀胱切除术后,采用肠段进行尿流改道和膀胱重建/替代。
Cochrane Database Syst Rev. 2003(1):CD003306. doi: 10.1002/14651858.CD003306.
7
Clinical utility of urinary comprehensive genomic profiling in diagnosing metachronous upper tract urothelial carcinoma: a case report.尿液综合基因组分析在诊断异时性上尿路尿路上皮癌中的临床应用:一例报告
Front Urol. 2023 Aug 9;3:1229709. doi: 10.3389/fruro.2023.1229709. eCollection 2023.
8
Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology Guidelines.根治性肾输尿管切除术作为多模式治疗策略一部分对出现区域淋巴结转移临床证据的上尿路尿路上皮癌患者的获益与危害:欧洲泌尿外科学会指南的系统评价和荟萃分析
Eur Urol Oncol. 2025 Jun;8(3):841-852. doi: 10.1016/j.euo.2024.12.009. Epub 2025 Jan 7.
9
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.经输尿管镜和经皮处理上尿路尿路上皮癌(UTUC):系统综述。
BJU Int. 2012 Sep;110(5):614-28. doi: 10.1111/j.1464-410X.2012.11068.x. Epub 2012 Apr 3.
10
Robot-assisted conversion of ureterocutaneous stoma to ileal conduit: a novel option for patients with post-cystectomy cutaneous diversion complicated by ureteral stricture and recurrent infections.机器人辅助下输尿管皮肤造口转回肠代膀胱术:膀胱切除术后皮肤转流并发输尿管狭窄和反复感染患者的一种新选择。
Front Urol. 2025 Aug 15;5:1634602. doi: 10.3389/fruro.2025.1634602. eCollection 2025.

本文引用的文献

1
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial Cancer.连续循环肿瘤DNA分析作为晚期尿路上皮癌微创生物标志物的临床应用价值
JCO Precis Oncol. 2025 Jan;9:e2400472. doi: 10.1200/PO-24-00472. Epub 2025 Jan 6.
2
Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy.根治性膀胱切除术后上尿路尿路上皮癌复发的累积发病率及危险因素
BJUI Compass. 2024 Feb 29;5(5):483-489. doi: 10.1002/bco2.336. eCollection 2024 May.
3
Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
膀胱癌根治性膀胱切除术后上尿路尿路上皮癌:根治性肾输尿管切除术的生存结局。
Ann Surg Oncol. 2024 Mar;31(3):2144-2153. doi: 10.1245/s10434-023-14710-x. Epub 2023 Dec 12.
4
Urothelial Carcinoma: Divergent Differentiation and Morphologic Subtypes.尿路上皮癌:不同分化和形态亚型。
Surg Pathol Clin. 2022 Dec;15(4):641-659. doi: 10.1016/j.path.2022.07.003. Epub 2022 Oct 13.
5
Robot-Assisted Nephroureterectomy for Upper Tract Urothelial Carcinoma in a Patient with an Ileal Conduit.机器人辅助肾输尿管切除术治疗回肠代膀胱患者的上尿路尿路上皮癌
Case Rep Urol. 2022 May 4;2022:5321613. doi: 10.1155/2022/5321613. eCollection 2022.
6
Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture.比较 Bricker 与 Wallace 输尿管-肠吻合术,并确定术后输尿管-肠吻合口狭窄的预测因素。
Langenbecks Arch Surg. 2022 May;407(3):1233-1240. doi: 10.1007/s00423-021-02413-4. Epub 2021 Dec 23.
7
Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy.内镜检查对上尿路尿路上皮癌根治性膀胱切除术后疑似患者的临床决策管理具有直接影响。
Urol Oncol. 2021 Oct;39(10):732.e1-732.e8. doi: 10.1016/j.urolonc.2021.03.002. Epub 2021 Apr 15.
8
Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.新辅助和辅助化疗治疗上尿路尿路上皮癌:2020 年系统评价和荟萃分析,以及系统治疗的未来展望。
Eur Urol. 2021 May;79(5):635-654. doi: 10.1016/j.eururo.2020.07.003. Epub 2020 Aug 12.
9
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.英菲格拉替尼在上尿路尿路上皮癌与膀胱癌中的疗效及其与全面基因组分析和/或游离细胞 DNA 结果的关系。
Cancer. 2020 Jun 1;126(11):2597-2606. doi: 10.1002/cncr.32806. Epub 2020 Mar 24.
10
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.在上尿路尿路上皮癌中的辅助化疗(POUT 试验):一项 3 期、开放标签、随机对照试验。
Lancet. 2020 Apr 18;395(10232):1268-1277. doi: 10.1016/S0140-6736(20)30415-3. Epub 2020 Mar 5.